Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi RJ and welcome!)Nice to have ya here.eom
Good morning all!)Heres to a GREEN day!!!)eom
YUP happens before LIFTOFF on these lotto plays!With BUYS all day they jus A either fullfilling the buys from earlier matching them up to the days vol or someone loading blocks.MMs could be accumulating too imo.Usually when one sees those blocks aftermark is when the fun begins shortly thereafter.Same happened to PDGT in the trip 0s and ran to pennyland so.Haps all the time.Tomorrow should be telling,rest of week will fer sure at least.DF
Another great thing IFSL still under the radar!)IF company makes the right moves for us holders then the rest is like clockwork!See ya manana and hoping 2s go out early in the AM!DF
Have a great evening playas!OTCS PICKIN UP TODAY its time for the next otc waveeeeee...Lets roll rest of week!!)DF
aha CLOCKWORK indeed!!)eom
lol righto!)Bring on the surprise Steve!!)See ya in the morn.Maybe we get our wish!DF
.59 close not too shabby will take it!)eom
2.40 close I will take it!)eom
Nuts look at SALI after close UT to 006 bid.Gapper tom?Looks like someone wants a slew..Catch yall then.DF
VERY nice to see.eom
More SOLID accumulation today!We could BLOW the top manana!)Bring on a BIG PR!)Check ya in the morn.DF
Yuppers!VERY strong close!Check yall in the morn nice to see the turn!DF
1@006,7,8,9 then 01s!eom
WOW STEW and AUTO on bid now too!1 left at 006 UTing into pennies!!!!!!!!!DF
LAMP on bid is NICE too!)005x6X006x4..THIN to pennies again!DF
Proceed.....
LOTS of good mms on bid!LAMPS here NICEEE!)0048x005x1..eom
last of the 2s here?Possibly!!eom
Yup and when Robo back off its on!)eom
IFSL here comes late day blocks 2s may fall into close with a few more!!!BRING IT!!
Here comes late day blocks!!eom
IFSL DOMS off ask onto bid now!!Not many 0002s left!)eom
lol right on!)eom
IFSL lotto ask thinning!3 left at 0002 now!Could fall here QUICK!!DF
IFSL ASK THINNING 3 left at 0002!!Bid building too!!eom
ASK THINNING 3 left!!Bid building too!!!eom
More on SPEX>>New Tagatose Partner (1 Rating) 27-Jun-07 01:19 pm Arla is out.....Nutrilab NV is in.
Gaio-Tagatose is out....Nutrilatose is in.
The Doc's chemical method is out.....enzymatic method is in.
Nutrilab NV (a Belgian company) bought Arla out of the tagatose project and is SPEX's new tagatose partner. They have prototype chocolates, an enzymatic manufacturing process, a new name for tagatose....Nutrilatose, and it should be on the market Feb 2008.
I am assuming Nutrilab is simply taking over the License from Arla and the license does stipulate that SPEX is still entitled to royalties (though at a lower rate) if the licensed product (tagatose) is manufcatured by a method other than the Doc's.
Judging from Nutrilab's comments on health benefits and claims, diabetes, drug use, etc....it appears to me they will be the Naturlose maunfacturer for SPEX as well.
IMO, this greatly reduces the risk of owning SPEX as it reopens the possibilty of tagatose food use revenues down the road....plus provides SPEX with Naturlose production in the event Naturlose ever cathes on....and if the enzymatic process is significanty cheaper, it should be easier to penetrate the food market.
http://www.toothfriendly.ch/fileadmin/me...
http://www.nutrilab.be/english/diet_prod...
http://www.nutrilab.be/english/health_be...
Hey LIFEEE!)eom
GET THIS TOO FROM QM>>New Tagatose Partner (1 Rating) 27-Jun-07 01:19 pm Arla is out.....Nutrilab NV is in.
Gaio-Tagatose is out....Nutrilatose is in.
The Doc's chemical method is out.....enzymatic method is in.
Nutrilab NV (a Belgian company) bought Arla out of the tagatose project and is SPEX's new tagatose partner. They have prototype chocolates, an enzymatic manufacturing process, a new name for tagatose....Nutrilatose, and it should be on the market Feb 2008.
I am assuming Nutrilab is simply taking over the License from Arla and the license does stipulate that SPEX is still entitled to royalties (though at a lower rate) if the licensed product (tagatose) is manufcatured by a method other than the Doc's.
Judging from Nutrilab's comments on health benefits and claims, diabetes, drug use, etc....it appears to me they will be the Naturlose maunfacturer for SPEX as well.
IMO, this greatly reduces the risk of owning SPEX as it reopens the possibilty of tagatose food use revenues down the road....plus provides SPEX with Naturlose production in the event Naturlose ever cathes on....and if the enzymatic process is significanty cheaper, it should be easier to penetrate the food market.
http://www.toothfriendly.ch/fileadmin/me...
http://www.nutrilab.be/english/diet_prod...
http://www.nutrilab.be/english/health_be...
WILL PROVIDE all needed for Phase 3 and getting TAG TO BE A MAJOR and STAND ALONE treatment to type 2 diabetes!HUGE implications here imo!!)DF
SPEX NEWS>>>>Spherix Signs Definitive Agreement for Sale of Information Subsidiary
Provides Update On Becoming A Biotech Company
BELTSVILLE, Md., June 27, 2007 /PRNewswire-FirstCall via COMTEX/ -- Spherix Incorporated (Nasdaq: SPEX) has signed the definitive agreement to sell the stock of its subsidiary, InfoSpherix Incorporated, to The Active Network Inc. Spherix will receive $17 million in an all cash transaction ($15 million at closing and $2 million following a 15-month escrow period). This combined with the $6 million received from the NRRS settlement (see Spherix press release dated October 26, 2006), will provide the necessary funding for Spherix's transition to a biotech company.
This matter will be put before Spherix's shareholders for vote at the 2007 Annual Shareholders Meeting. The Annual Meeting is tentatively scheduled to be held mid- to late-August, pending timely approval of the Proxy Statement by the SEC. Closing will occur within a few days following shareholder approval.
The sale will allow Spherix to become a funded biotech company, whose main priority will be to commercialize Naturlose(R), which the Company is currently studying as a treatment for Type 2 diabetes through a large-scale Phase 3 clinical trial. Company officials recently met with representatives from its Contract Research Organizations in the U.S. and Australia, and with the majority of the principal investigators. The trial, which began earlier this year, is progressing as planned, with testing scheduled to finish in early 2009.
Richard Levin, Spherix CEO and President, said, "We are pleased at the enthusiasm expressed for our product at the investigator meetings, and completion of this trial will be a major step in the commercialization of Naturlose. The consummation of this deal will allow Spherix to complete the Phase 3 trial, better position Naturlose for the diabetes market, and permit us to complete other research."
Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on March 3, 1999.
About Spherix Incorporated
Under its motto, "A World of Solutions," Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in information technology, knowledge management, and biotechnology. InfoSpherix designs, hosts, and operates real-time business and contact center solutions for government agencies, with a major focus on public park agencies. InfoSpherix is a wholly owned subsidiary of Spherix Incorporated, based in Beltsville, Maryland. After the sale of InfoSpherix, Spherix will devote its full effort to the new biotech company.
About The Active Network, Inc.
The Active Network, Inc., based in San Diego, Calif., provides application services technology and marketing access to community service and participatory sports organizations, and is a leading online community for active lifestyles.
Spherix's Internet address is http://www.spherix.com.
SPEX NEWSSSSSSSSSSS HUGEEEEE!!Spherix Signs Definitive Agreement for Sale of Information Subsidiary
Provides Update On Becoming A Biotech Company
BELTSVILLE, Md., June 27, 2007 /PRNewswire-FirstCall via COMTEX/ -- Spherix Incorporated (Nasdaq: SPEX) has signed the definitive agreement to sell the stock of its subsidiary, InfoSpherix Incorporated, to The Active Network Inc. Spherix will receive $17 million in an all cash transaction ($15 million at closing and $2 million following a 15-month escrow period). This combined with the $6 million received from the NRRS settlement (see Spherix press release dated October 26, 2006), will provide the necessary funding for Spherix's transition to a biotech company.
This matter will be put before Spherix's shareholders for vote at the 2007 Annual Shareholders Meeting. The Annual Meeting is tentatively scheduled to be held mid- to late-August, pending timely approval of the Proxy Statement by the SEC. Closing will occur within a few days following shareholder approval.
The sale will allow Spherix to become a funded biotech company, whose main priority will be to commercialize Naturlose(R), which the Company is currently studying as a treatment for Type 2 diabetes through a large-scale Phase 3 clinical trial. Company officials recently met with representatives from its Contract Research Organizations in the U.S. and Australia, and with the majority of the principal investigators. The trial, which began earlier this year, is progressing as planned, with testing scheduled to finish in early 2009.
Richard Levin, Spherix CEO and President, said, "We are pleased at the enthusiasm expressed for our product at the investigator meetings, and completion of this trial will be a major step in the commercialization of Naturlose. The consummation of this deal will allow Spherix to complete the Phase 3 trial, better position Naturlose for the diabetes market, and permit us to complete other research."
Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on March 3, 1999.
About Spherix Incorporated
Under its motto, "A World of Solutions," Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in information technology, knowledge management, and biotechnology. InfoSpherix designs, hosts, and operates real-time business and contact center solutions for government agencies, with a major focus on public park agencies. InfoSpherix is a wholly owned subsidiary of Spherix Incorporated, based in Beltsville, Maryland. After the sale of InfoSpherix, Spherix will devote its full effort to the new biotech company.
About The Active Network, Inc.
The Active Network, Inc., based in San Diego, Calif., provides application services technology and marketing access to community service and participatory sports organizations, and is a leading online community for active lifestyles.
Spherix's Internet address is http://www.spherix.com.
DID I CALL IT OR WHAT?NEWSSSSSSSSSSSSS>>>>
Spherix Signs Definitive Agreement for Sale of Information Subsidiary
Provides Update On Becoming A Biotech Company
BELTSVILLE, Md., June 27, 2007 /PRNewswire-FirstCall via COMTEX/ -- Spherix Incorporated (Nasdaq: SPEX) has signed the definitive agreement to sell the stock of its subsidiary, InfoSpherix Incorporated, to The Active Network Inc. Spherix will receive $17 million in an all cash transaction ($15 million at closing and $2 million following a 15-month escrow period). This combined with the $6 million received from the NRRS settlement (see Spherix press release dated October 26, 2006), will provide the necessary funding for Spherix's transition to a biotech company.
This matter will be put before Spherix's shareholders for vote at the 2007 Annual Shareholders Meeting. The Annual Meeting is tentatively scheduled to be held mid- to late-August, pending timely approval of the Proxy Statement by the SEC. Closing will occur within a few days following shareholder approval.
The sale will allow Spherix to become a funded biotech company, whose main priority will be to commercialize Naturlose(R), which the Company is currently studying as a treatment for Type 2 diabetes through a large-scale Phase 3 clinical trial. Company officials recently met with representatives from its Contract Research Organizations in the U.S. and Australia, and with the majority of the principal investigators. The trial, which began earlier this year, is progressing as planned, with testing scheduled to finish in early 2009.
Richard Levin, Spherix CEO and President, said, "We are pleased at the enthusiasm expressed for our product at the investigator meetings, and completion of this trial will be a major step in the commercialization of Naturlose. The consummation of this deal will allow Spherix to complete the Phase 3 trial, better position Naturlose for the diabetes market, and permit us to complete other research."
Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on March 3, 1999.
About Spherix Incorporated
Under its motto, "A World of Solutions," Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in information technology, knowledge management, and biotechnology. InfoSpherix designs, hosts, and operates real-time business and contact center solutions for government agencies, with a major focus on public park agencies. InfoSpherix is a wholly owned subsidiary of Spherix Incorporated, based in Beltsville, Maryland. After the sale of InfoSpherix, Spherix will devote its full effort to the new biotech company.
About The Active Network, Inc.
The Active Network, Inc., based in San Diego, Calif., provides application services technology and marketing access to community service and participatory sports organizations, and is a leading online community for active lifestyles.
Spherix's Internet address is http://www.spherix.com.
IFSL 0001x10X0002x4..ALL buys today.2s fall its on imo!)They did yesterday for a min after the 9 mil blocks hit.Jus a matter of time imo.Now also word from another poster that was in contact with CEO about buyback(PR this and lotto players flock imo)!!!!Also company trying to get the pps up as they dont believe it reflects their current doings.Now IF they take us shareholders advice and retire shares along with buyback then this could turn into a golden ticket.HAve hope here and I never thought Id touch that one again.Got that feelin here.DF
GG there Mo.May have to move to IFSL next cool?!)hehe eom
Maybe the news we have been waitin for is around the corner!)! We have phase 3 news to look forward too,approval and BOOM.Also toothpaste,tooth study/deal.As well as sale of Info division.I be ready!!DF
WAKING UP KIM!!! 2.35 news coming???BRING ITTT!!eom
SPEX waking up.2.32!)Member IN phase 3 clinical trials now.Imagine when FDA approves what will happen with barely any shares in the float!
SPEX WAKING UP!!!News coming??Type 2 diabetes Phase 3 IN CLINICAL trials NOW and has cash NO LT DEBT!Imagine the move with under 8 mil float if approved!!)DF